Catalog No.: PC-43263Not For Human Use, Lab Use Only.
CB-5083 is a potent, selective, orally bioavailable inhibitor of p97/VCP AAA ATPase with IC50 of 11 nM, specifically targets D2 ATPase site of p97, shows 9.6, 128 and 158-fold less affinity for DNA-PK, mTOR and PIK3C3.
CB-5083 is a potent, selective, orally bioavailable inhibitor of p97/VCP AAA ATPase with IC50 of 11 nM, specifically targets D2 ATPase site of p97, shows 9.6, 128 and 158-fold less affinity for DNA-PK, mTOR and PIK3C3.
CB-5083 causes accumulation of poly-ubiquitinated proteins, retention of ERAD substrates, and generation of irresolvable proteotoxic stress, leading to activation of the apoptotic arm of the unfolded protein response (UPR) in cancer cells.
CB-5083 inhibits A549 cell viability with IC50 of 0.67 uM, induces the UPR and apoptosis in xenograft tumor models.
